MedPath

Evaluation of probiotic usage on the intestinal microbiota diversity in patiets whith celiac disease; a clinical trial study

Phase 3
Recruiting
Conditions
Celiac.
Disease of intestine, unspecified
K63.9
Registration Number
IRCT20171225038063N1
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
31
Inclusion Criteria

Patient under gluten-free diet(GFD)
Confermed having celiac disease based on serology and pathology tests

Exclusion Criteria

Pregnancy
People with the disease Crohn, colitis ulcerative, short bowel syndrome, mouth and stomach surgery, cancer and hepatitis
Use of steroids, antibiotics, and nonsteroidal anti-inflammatory drug 4 weeks before the study
Alcohol consumption

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Fold change in abundance of intestinal Microbiota of patients with celiac disease. Timepoint: 3 months. Method of measurement: Real Time PCR.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath